Cas No.: | 1073549-10-6 |
Chemical Name: | (S)-4'-((2-ethoxy-4-ethyl-5-((2-mercapto-4-methylpentanamido)methyl)-1H-imidazol-1-yl)methyl)-3'-fluoro-[1,1'-biphenyl]-2-carboxylic acid |
Synonyms: | TD0212;TD 0212 |
SMILES: | C(C1=CC=C(CN2C(OCC)=NC(CC)=C2CNC(=O)[C@H](S)CC(C)C)C(F)=C1)1=CC=CC=C1C(O)=O |
Formula: | C28H34FN3O4S |
M.Wt: | 527.655 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | TD-0212 (TD0212) is a potent, orally efficacious, dual AT1 antagonist/Neprilysin (NEP) inhibitor with pKi of 8.9 (AT1) and pIC50 of 9.2 (NEP); produces blood pressure reductions similar to omapatrilat and combinations of AT1 receptor antagonists and NEP inhibitors in models of renin-dependent and -independent hypertension, does not increase TPE at antihypertensive doses in rat tracheal plasma extravasation (TPE) models. |